SEC Company Response from ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550) (CLPT) — Aug 5, 2016
ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550)
Date: Aug. 5, 2016 · CIK: 0001285550 · Accession: 0001534424-16-000933
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-211647
Letter
ROTH CAPITAL PARTNERS, LLC
888 San Clemente Drive
Suite 400
Newport Beach, California 92660
August 5, 2016
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: MRI Interventions, Inc.
Registration Statement on Form S-1
File No. 333-211647
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, ROTH Capital Partners, LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:01 p.m., Eastern Time, on August 8, 2016, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
ROTH CAPITAL PARTNERS, LLC
Show Raw Text
CORRESP
1
filename1.htm
ROTH
CAPITAL PARTNERS, LLC
888 San Clemente Drive
Suite 400
Newport Beach, California 92660
August 5, 2016
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: MRI Interventions, Inc.
Registration Statement on Form S-1
File No. 333-211647
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 of the General
Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, ROTH Capital
Partners, LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced
Registration Statement so that it will become effective at 4:01 p.m., Eastern Time, on August 8, 2016, or as soon thereafter as
practicable.
Pursuant to Rule 460 under the Securities
Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to be invited
to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to
be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has
complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they
have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection
with the above-referenced issue.
Very truly yours,
ROTH CAPITAL PARTNERS, LLC
By:
/s/ Aaron Gurewitz
Name:
Aaron Gurewitz
Title:
Head of Equity Capital Markets